The bioresorbable Cordis Mynx Grip vascular closure device seals arteriotomies without use of permanent hardware.

The bioresorbable Cordis MynxGrip vascular closure device seals arteriotomies without use of permanent hardware.

Feature | Vascular Closure Devices | January 22, 2018 | Dave Fornell

While manual compression remains the gold standard for hemostasis of catheterization vascular access site...

FDA Issues Safety Communication on Zoll LifeVest 4000 Wearable Cardioverter Defibrillator
News | Wearable Sensors | January 22, 2018

January 22, 2018 — The U.S. Food and Drug Administration (FDA) announced last week it is providing information and...

Baxter Announces FDA Approval of Ready-to-Use Cardiovascular Medication Bivalirudin
Technology | Antiplatelet and Anticoagulation Therapies | January 22, 2018

January 22, 2018 — Baxter International Inc. announced the U.S. Food and Drug Administration (FDA) approval of...

Ligand Establishes Program to Develop Captisol-Enabled, Next-Generation Diagnostic Imaging Contrast Agents
News | Contrast Media | January 19, 2018

January 19, 2018 — Ligand Pharmaceuticals Inc. announced initiation of a program to develop...

Abbott Announces European Launch of Advisor HD Grid Mapping Catheter, Sensor Enabled
Technology | EP Mapping and Imaging Systems | January 19, 2018

January 19, 2018 — Abbott last week announced CE Mark approval for the company's new Advisor HD Grid Mapping...

News | Antiplatelet and Anticoagulation Therapies | January 19, 2018

January 19, 2018 — The U.S. Food and Drug Administration (FDA) announced that International Laboratories LLC is...

National Clinical Decision Support Company (NDSC) has an exclusive deal with the American College of Radiology (ACR) to provide medical imaging appropriate use criteria (AUC).

National Clinical Decision Support Company (NDSC) has an exclusive deal with the American College of Radiology (ACR) to provide medical imaging appropriate use criteria (AUC). 

Feature | Clinical Decision Support | January 18, 2018

January 18, 2018 — Change Healthcare announced the acquisition of National Decision Support Company (NDSC), a leader...

West Hills Hospital & Medical Center Ranked No. 1 in Los Angeles County for Door-to-Balloon Time
News | Stents Bifurcation | January 18, 2018

January 18, 2018 – West Hills Hospital & Medical Center, a full-service acute care...

J&J Announces U.S. IDE Study to Evaluate Potential of New Device to Reduce Stroke Risk in Afib
News | Left Atrial Appendage (LAA) Occluders | January 18, 2018

January 18, 2018 – Johnson & Johnson Medical Devices Companies announced that Biosense Webster, Inc., a...

A live Corevalve TAVR case in the main arena at TCT 2017. Structural heart has moved from a science fiction discussion in future technology sessions at TCT a decade ago to now being a major portion of what the conference discusses for today's clinical practice.

A live CoreValve TAVR case in the main arena at TCT 2017. Structural heart has moved from a science fiction discussion in future technology sessions at TCT a decade ago to now being a major portion of what the conference discusses for today's clinical practice.

Blog | TCT | January 18, 2018

Here is a list of what I think were some of the top interventional technologies discussed at the 2017 Transcatheter...

The Abbott Absorb Bioresorbable Vascular Scaffold (BVS) bioabsorbable stent.

The Abbott Absorb Bioresorbable Vascular Scaffold (BVS).

Feature | Stents Drug Eluting | January 17, 2018 | Dave Fornell

There was no shortage of interest in bioresorbable stent technologies at the many sessions offered on this topic or...

Philips Introduces Technology Maximizer Program for Imaging Equipment Upgrades
Technology | Cardiac Imaging | January 17, 2018

January 17, 2018 — Philips recently announced the launch of Technology Maximizer, a cross-modality program designed...

New Vascular Ultrasound Registry Looks to Enhance Patient Care
News | Cardiovascular Ultrasound | January 17, 2018

January 17, 2018 — The Society for Vascular Ultrasound (SVU), the Society for Vascular Surgery (SVS) and...

Secant Introduces First Synthetic Regenerative Cardiovascular Graft for CABG
News | Stem Cell Therapies | January 17, 2018

January 17, 2018 — Secant Group, in partnership with its sister company SanaVita Medical, announced new technology...

Russian Team Developing New Technology to Significantly Reduce MRI Research Costs
News | Magnetic Resonance Imaging (MRI) | January 16, 2018

January 16, 2018 — Researchers from the NUST MISIS Engineering Center for Industrial Technologies in Russia have...

Overlay Init